DK208787A - Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf - Google Patents

Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf

Info

Publication number
DK208787A
DK208787A DK208787A DK208787A DK208787A DK 208787 A DK208787 A DK 208787A DK 208787 A DK208787 A DK 208787A DK 208787 A DK208787 A DK 208787A DK 208787 A DK208787 A DK 208787A
Authority
DK
Denmark
Prior art keywords
pharmaceutical acceptable
preparation
quinoline derivatives
acceptable salts
esters
Prior art date
Application number
DK208787A
Other languages
Danish (da)
English (en)
Other versions
DK208787D0 (da
Inventor
Jun-Ichi Matsumoto
Teruyuki Miyamoto
Hiroshi Egawa
Shinishi Nakamura
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of DK208787D0 publication Critical patent/DK208787D0/da
Publication of DK208787A publication Critical patent/DK208787A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK208787A 1986-04-25 1987-04-24 Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf DK208787A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9754386 1986-04-25

Publications (2)

Publication Number Publication Date
DK208787D0 DK208787D0 (da) 1987-04-24
DK208787A true DK208787A (da) 1987-10-26

Family

ID=14195155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK208787A DK208787A (da) 1986-04-25 1987-04-24 Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf

Country Status (17)

Country Link
US (1) US4886810A (pt)
EP (1) EP0242789A3 (pt)
JP (1) JP2572591B2 (pt)
KR (1) KR870010005A (pt)
CN (1) CN87103138A (pt)
AU (1) AU7190987A (pt)
DD (1) DD263290A5 (pt)
DK (1) DK208787A (pt)
FI (1) FI871788A (pt)
HU (1) HU198198B (pt)
IL (1) IL82246A0 (pt)
NO (1) NO871727L (pt)
PH (1) PH23326A (pt)
PT (1) PT84749B (pt)
SU (3) SU1582986A3 (pt)
YU (4) YU73987A (pt)
ZA (1) ZA872874B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
ATE75740T1 (de) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
NO885426L (no) * 1987-12-11 1989-06-12 Dainippon Pharmaceutical Co Kinolinderivater, samt fremgangsmaate ved fremstilling derav.
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US5585491A (en) * 1988-01-25 1996-12-17 Otsuka Pharmaceutical Co., Ltd. Antibacterial agents
DE3814517A1 (de) * 1988-02-05 1989-08-17 Bayer Ag Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JPH0674261B2 (ja) * 1988-06-21 1994-09-21 塩野義製薬株式会社 キノロンカルボン酸誘導体
US5057523A (en) * 1988-09-22 1991-10-15 Abbott Laboratories Dipeptide quinolone derivatives
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
CA2058424A1 (en) * 1989-07-21 1991-01-22 Akihiro Shibata Quinoline carboxylic acid derivatives
ES2019551A6 (es) * 1990-04-11 1991-06-16 Ercros Sa Procedimiento para la obtencion de derivados del acido 6-fluor-1, 4-dihidro-4-oxo-7-piperacinil-3-quinlincarboxilico.
ES2147721T3 (es) 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
US5221676A (en) * 1992-02-06 1993-06-22 Warner-Lambert Company 7-substituted quinolones and naphthyridones as antibacterial agents
EP0677522A4 (en) * 1992-12-28 1995-12-27 Yoshitomi Pharmaceutical 8-METHOXYQUINOLONECARBOXYLIC ACID DERIVATIVE.
CA2152828A1 (en) * 1993-03-16 1994-07-07 Shin-Ichi Uesato 8-methoxy-quinolonecarboxylic acid derivatives
TW252107B (pt) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
AU8003594A (en) * 1993-10-28 1995-05-22 Kaken Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative and salt thereof
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates
JPH10504815A (ja) * 1994-08-02 1998-05-12 ザ、プロクター、エンド、ギャンブル、カンパニー 抗微生物化合物の製造方法
WO1996022988A1 (fr) * 1995-01-24 1996-08-01 Hokuriku Seiyaku Co., Ltd. Derives de l'acide quiloleine carboxylique
MY132897A (en) * 1997-06-24 2007-10-31 Daiichi Seiyaku Co Cis- substituted fluoromethylpyrrolidine derivative
JP4639149B2 (ja) * 2003-09-10 2011-02-23 杏林製薬株式会社 ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
JP5063032B2 (ja) * 2005-05-19 2012-10-31 第一三共株式会社 トリ−、テトラ−置換−３−アミノピロリジン誘導体
JP5197606B2 (ja) 2007-01-05 2013-05-15 第一三共株式会社 フューズ置換型アミノピロリジン誘導体
WO2008143343A1 (ja) * 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
ZA852369B (en) * 1984-04-26 1985-12-24 Abbott Lab Quinoline antibacterial compounds
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4771054A (en) * 1985-01-23 1988-09-13 Warner-Lambert Company Antibacterial agents
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids

Also Published As

Publication number Publication date
YU27688A (en) 1988-12-31
EP0242789A3 (en) 1990-09-05
SU1588282A3 (ru) 1990-08-23
ZA872874B (en) 1987-10-12
SU1582986A3 (ru) 1990-07-30
AU7190987A (en) 1987-10-29
IL82246A0 (en) 1987-10-30
JP2572591B2 (ja) 1997-01-16
YU27488A (en) 1988-10-31
EP0242789A2 (en) 1987-10-28
NO871727L (no) 1987-10-26
PT84749B (en) 1989-06-07
KR870010005A (ko) 1987-11-30
YU73987A (en) 1988-08-31
DD263290A5 (de) 1988-12-28
NO871727D0 (no) 1987-04-24
US4886810A (en) 1989-12-12
YU27788A (en) 1990-04-30
JPS6345261A (ja) 1988-02-26
PH23326A (en) 1989-07-14
HU198198B (en) 1989-08-28
HUT45520A (en) 1988-07-28
SU1588281A3 (ru) 1990-08-23
FI871788A0 (fi) 1987-04-23
PT84749A (en) 1987-05-01
DK208787D0 (da) 1987-04-24
FI871788A (fi) 1987-10-26
CN87103138A (zh) 1987-11-04

Similar Documents

Publication Publication Date Title
DK208787A (da) Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf
DK290188A (da) Alkoxysubstituerede dihydrobenzopyran-2-carboxylatderivater og farmaceutiske acceptable salte deraf samt deres anvendelse
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK434488D0 (da) Heteroarylethere og heteroaromatiske n-oxider eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK25992D0 (da) Quinolinderivater, deres fremstilling samt farmaeutisk praeparat indeholdende saadanne derivater
DK181983D0 (da) 1,8-naphthyridin- og 1,5,8-azanaphthyridin-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK52388D0 (da) Polyaminderivater samt fremgangsmaader til deres fremstilling
DK217787A (da) Substituerede 2,4-diamino-5-cyano-pyrimidiner og salte deraf samt deres fremstilling og anvendelse
DK519189D0 (da) Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK461389A (da) Quinolyloxazol-2-oner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK673988A (da) Manumycinderivater, fremgangsaader til deres fremstilling samt deres anvendelse
DK303688A (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK573788D0 (da) Quinolinderivater eller farmaceutiske acceptable estere eller salte deraf, deres fremstilling og anvendelse
DK38587A (da) Mono- og disaccharidylderivater og salte deraf samt deres fremstilling og anvendelse
DK393788A (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK183886D0 (da) 4-phenylpropylindolderivater og deres salte og fremgangsmaade til deresfremstilling samt deres anvendelse som laegemidler
DK688888D0 (da) Substituerede 1,4-dihydro-4-oxoquinolin-3-carboxylsyrer, farmaceutisk acceptable estre eller salte deraf, deres fremstilling og anvendelse
DK79687D0 (da) N-substituerede saframycinderivater og salte deraf samt deres fremstilling og anvendelse
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK624288A (da) 3-substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK378989D0 (da) Halogenvinylazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse
DK530388A (da) Pyrrolo-(1,2-b)cinnoliner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK72887A (da) 2-aminoacyloxymethyl-2-penem-forbindelser og salte deraf samt deres fremstilling og anvendelse
DK436588A (da) Substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK264788A (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment